JPCCM
PTLA

J&P (China) Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

J&P (China) Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,300
Closed -$183K – 21
2015
Q3 		$183K Hold
4,300
– – 0.04% 15
2015
Q2 		$196K Hold
4,300
– – 0.03% 17
2015
Q1 		$163K Buy
+4,300
New +$148K 0.02% 23

Other funds holding PTLA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

J&P (China) Capital Management's PTLA Position: Q4 2015 in Review

J&P (China) Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2015, closing a stake of 4,300 shares — an estimated $183K sold.

J&P (China) Capital Management first reported a position in PTLA in Q1 2015 and held it in 3 quarters. The position peaked at $196K in Q2 2015. 190 funds tracked by Wall St. Rank hold PTLA as of Q4 2015.

  • J&P (China) Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • J&P (China) Capital Management sold 4,300 Portola Pharmaceuticals, Inc. shares in Q4 2015, an estimated $183K.
  • J&P (China) Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • J&P (China) Capital Management's Portola Pharmaceuticals, Inc. position peaked at $196K in Q2 2015.
  • 190 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2015.

Based on J&P (China) Capital Management's 13F filing for Q4 2015, filed 29 Jan 2016.